Рак поджелудочной железы - Состав тела, искусственный интеллект, иммунотерапия. Новости онкологии 4 неделя ноября

Врач-онколог Федоринов Денис Сергеевич Источники литературы: 1. Damm M, Efremov L, Jalal M, Nadeem N, Dober J, Michl P, Wohlgemuth WA, Wadsley J, Hopper AD, Krug S, Rosendahl J. Body composition parameters predict survival in pancreatic cancer-A retrospective multicenter analysis. United European Gastroenterol J. 2023 Nov 21. doi: Epub ahead of print. PMID: 37987099. 2. Hayashi K, Kitago M, Abe Y, Yagi H, Hasegawa Y, Hori S, Tanaka M, Nakano Y, Asakura K, Masugi Y, Kitagawa Y. Long-term survival after surgical resection for bone metastasis from pancreatic cancer: A case report. Medicine (Baltimore). 2023 Nov 17;102(46):e35856. doi: PMID: 37986361. 3. Cao K, Xia Y, Yao J, Han X, Lambert L, Zhang T, Tang W, Jin G, Jiang H, Fang X, Nogues I, Li X, Guo W, Wang Y, Fang W, Qiu M, Hou Y, Kovarnik T, Vocka M, Lu Y, Chen Y, Chen X, Liu Z, Zhou J, Xie C, Zhang R, Lu H, Hager GD, Yuille AL, Lu L, Shao C, Shi Y, Zhang Q, Liang T, Zhang L, Lu J. Large-scale pancreatic cancer detection via non-contrast CT and deep learning. Nat Med. 2023 Nov 20. doi: Epub ahead of print. PMID: 37985692. 4. Yun WG, Han Y, Cho YJ, Jung HS, Lee M, Kwon W, Jang JY. In Neoadjuvant FOLFIRINOX Chemotherapy for Pancreatic Ductal Adenocarcinoma, Which Response is the More Reliable Indicator for Prognosis, Radiologic or Biochemical? Ann Surg Oncol. 2023 Nov 22. doi: Epub ahead of print. PMID: 37991581. 5. Leonhardt CS, Stamm T, Hank T, Prager G, Strobel O. Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus. ESMO Open. 2023 Nov 20;8(6):102067. doi: Epub ahead of print. PMID: 37988953. 6. Melisi D, Zecchetto C, Merz V, Malleo G, Landoni L, Quinzii A, Casalino S, Fazzini F, Gaule M, Pesoni C, Casetti L, Esposito A, Marchegiani G, Piazzola C, D’Onofrio M, de Robertis R, Gabbrielli A, Bernardoni L, Crino SF, Pietrobono S, Luchini C, Aliberti C, Martignoni G, Milleri S, Butturini G, Scarpa A, Salvia R, Bassi C. Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial. Eur J Cancer. 2023 Nov 11;196:113430. doi: Epub ahead of print. PMID: 37995598. 7. Sakakida T, Ishikawa T, Doi T, Morita R, Kataoka S, Miyake H, Yamaguchi K, Moriguchi M, Sogame Y, Yasuda H, Iwasaku M, Konishi H, Takayama K, Itoh Y. Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database. J Gastroenterol. 2023 Nov 25. doi: Epub ahead of print. PMID: 38006445.